KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $748,000 | +68.1% | 4,207 | -2.0% | 0.04% | +63.6% |
| Q2 2017 | $445,000 | +55.1% | 4,292 | +17.5% | 0.02% | +57.1% |
| Q1 2017 | $287,000 | +20.6% | 3,654 | -29.7% | 0.01% | -12.5% |
| Q1 2016 | $238,000 | -71.2% | 5,200 | -61.2% | 0.02% | -71.4% |
| Q4 2015 | $825,000 | +10.6% | 13,400 | 0.0% | 0.06% | +5.7% |
| Q3 2015 | $746,000 | -8.6% | 13,400 | 0.0% | 0.05% | -1.9% |
| Q2 2015 | $816,000 | +36.2% | 13,400 | +28.8% | 0.05% | +38.5% |
| Q1 2015 | $599,000 | – | 10,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|